India News | Serum Institute Resumes COVID-19 Vaccine Exports
Get latest articles and stories on India at LatestLY. Serum Institute of India -- the world's largest vaccine maker -- on Friday said it has resumed exports of Covishield vaccine to low- and middle-income countries with the first batch of consignment leaving its Pune facility.
New Delhi, Nov 26 (PTI) Serum Institute of India -- the world's largest vaccine maker -- on Friday said it has resumed exports of Covishield vaccine to low- and middle-income countries with the first batch of consignment leaving its Pune facility.
The vaccine maker has cumulatively produced 1.25 billion doses so far, a company statement said.
Also Read | Sensex Declines 1,687 Points As New COVID-19 Variant Emerges in South Africa.
"The first batches of its COVISHIELD COVID-19 vaccine left the SII manufacturing facility in Pune earlier today, for distribution to low- and middle-income countries via the COVAX mechanism," it said.
"SII's supply of doses via COVAX is expected to increase substantially into Quarter 1 2022," it added.
Also Read | Xiaomi 12 Likely To Be Launched on December 12, 2021: Report.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)